Schurpf, Thomas,Datta, Abhishek,Carven, Gregory J.,Martin, Constance,Kalra, Ashish,Long, Kimberly,Buckler, Alan
申请号：
AU2018205231
公开号：
AU2018205231A1
申请日:
2018.01.05
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGFβ1 in the treatment of disease that involve TGFβ1 dysregulation.
